Universe Pharmaceuticals (UPC) Shares Issued (2020 - 2021)

Universe Pharmaceuticals (UPC) reported Shares Issued of $100.0 million for Q3 2021, little changed on a YoY basis from $100.0 million in Q3 2020, and little changed sequentially from $100.0 million in Q3 2020.

Universe Pharmaceuticals (UPC) Shares Issued (2020 - 2021) Analysis & Trends

Universe Pharmaceuticals (UPC) has 2 years of Shares Issued data on file, last reported at $100.0 million in Q3 2021.

  • For the quarter ending Q3 2021, Shares Issued changed 0.0% year-over-year to $100.0 million; the trailing twelve-month figure through Sep 2021 stood at $100.0 million (changed 0.0% YoY), and the FY2021 full-year result was $100.0 million, changed 0.0% from the prior year.
  • Shares Issued was little changed at $100.0 million in Q3 2021, from $100.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $100.0 million in Q3 2020 to a low of $100.0 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2021 100.00 Mn
Sep 30, 2021 100.00 Mn
Sep 30, 2020 100.00 Mn
Sep 30, 2020 100.00 Mn